Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-032864

Chief Financial Officer gave up 30,485 shares (to pay taxes)

  • Chief Financial Officer acquired 130,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster Jonathan P. Chief Financial Officer 2026-10-15 Option exercise +130,000 435,673 D: show line 1 in the form
Foster Jonathan P. Chief Financial Officer 2026-10-15 Shares withheld for taxes −30,485 $0.37 $11,282 405,188 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Foster Jonathan P. Chief Financial Officer 2026-10-15 Grant or award · Stock Options (right to buy) +260,000 1,287,717 D: show line 3 in the form
Foster Jonathan P. Chief Financial Officer 2026-10-15 Grant or award · Restricted Stock Units +260,000 1,547,717 D: show line 4 in the form
Foster Jonathan P. Chief Financial Officer 2026-10-15 Option exercise · Restricted Stock Units −130,000 1,417,717 D: show line 5 in the form
Loading xslF345X06/rdgdoc.xml…